Pdt Partners, LLC Theravance Biopharma, Inc. Transaction History

Pdt Partners, LLC

$981 Million
Q2 2024

A detailed history of Pdt Partners, LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 66,439 shares of TBPH stock, worth $538,155. This represents 0.06% of its overall portfolio holdings.

Number of Shares

66,439

Previous 66,439 -0.0%

Holding current value

$538,155

Previous $595,000 5.38%

% of portfolio

0.06%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.22 - $11.59 $279,611 - $394,245	34,016 Added 104.91%	66,439 $595,000
Q4 2023 Feb 14, 2024	SELL	$8.58 - $11.4 $420,720 - $558,999	-49,035 Reduced 60.2%	32,423 $364,000
Q3 2023 Nov 14, 2023	SELL	$8.38 - $10.44 $5,866 - $7,308	-700 Reduced 0.85%	81,458 $702,000
Q2 2023 Aug 14, 2023	SELL	$10.16 - $11.92 $2,062 - $2,419	-203 Reduced 0.25%	82,158 $850,000
Q1 2023 May 15, 2023	BUY	$9.87 - $11.44 $384 - $446	39 Added 0.05%	82,361 $893,000
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $6,407 - $7,529	664 Added 0.81%	82,322 $923,000
Q3 2022 Nov 14, 2022	SELL	$8.39 - $10.22 $624,828 - $761,114	-74,473 Reduced 47.7%	81,658 $828,000
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $307,553 - $378,133	-36,570 Reduced 18.98%	156,131 $1.42 Million
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $677,412 - $1.05 Million	81,322 Added 73.01%	192,701 $1.84 Million
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $826,432 - $1.23 Million	111,379 New	111,379 $1.23 Million
Q1 2021 May 17, 2021	SELL	$16.57 - $21.08 $903,429 - $1.15 Million	-54,522 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $171,815 - $232,626	-11,539 Reduced 17.47%	54,522 $969,000
Q3 2020 Nov 16, 2020	BUY	$14.79 - $22.49 $613,001 - $932,143	41,447 Added 168.39%	66,061 $977,000
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $508,032 - $755,403	24,614 New	24,614 $517,000

Others Institutions Holding TBPH

# of Institutions

134

Shares Held

48.7M

Call Options Held

13.9K

Put Options Held

3.1K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $541M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account